New hope for tough uterine cancers: experimental drug trial opens
Disease control
Not yet recruiting
This study is testing whether the drug enfortumab vedotin can help control advanced endometrial (uterine) cancer that has worsened despite previous treatments. Up to 12 patients whose cancer has progressed after chemotherapy and immunotherapy will receive the drug for up to one y…
Phase: PHASE2 • Sponsor: William Bradley • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC